Home/Oxford Expression Technologies/Professor Robert Possee
PR

Professor Robert Possee

Board Member

Oxford Expression Technologies

Therapeutic Areas

Oxford Expression Technologies Pipeline

DrugIndicationPhase
Novel Covid-19 VaccineCOVID-19Pre-clinical
CCHF Virus VaccineCrimean-Congo Haemorrhagic FeverPre-clinical